Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain
Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States. Shares Read More




















